REGEN BIOPHARMA, INC. Other Income and Expense
REGEN BIOPHARMA, INC. (RGBP) reported Other Income and Expense of -$449.06 thousand for the 12-month period ending 2024-09-30, per its 8-K filed 2024-11-29.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2024-11-29
- REGEN BIOPHARMA, INC. nonoperating income (expense) for the quarter ending 2023-12-31 was -$226.98K, a 110.81% decline year-over-year.
- REGEN BIOPHARMA, INC. nonoperating income (expense) for the quarter ending 2022-12-31 was $2.10M.
- REGEN BIOPHARMA, INC. nonoperating income (expense) for fiscal 2023 was $1.84M, a 33.76% decline from fiscal 2022.
- REGEN BIOPHARMA, INC. nonoperating income (expense) for fiscal 2022 was $2.78M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 12 month |
|---|---|---|
| 2024-09-30 | -$449.06K 8-K · filed 2024-11-29 | |
| 2023-12-31 | -$226.98K 10-Q · filed 2024-01-19 | |
| 2023-09-30 | $1.84M 10-K · filed 2023-11-20 | |
| 2022-12-31 | $2.10M 10-Q · filed 2024-01-19 | |
| 2022-09-30 | $2.78M 10-K · filed 2023-11-20 |